Article
A DNA Vaccine Inducing T Cell Responses Against CCHF: From in silico to in vivo
2025-05-22
Abstract excerpt
<title>Abstract</title> <p><bold>Objectives</bold> Crimean-Congo Hemorrhagic Fever is a severe viral disease with high fatality rates, and no approved vaccine is currently available. This study aimed to design and evaluate a multi-epitope recombinant vaccine for Crimean-Congo Hemorrhagic Fever using computational and in vitro approaches. The data presented in this study were generated to assess the immunogenic po...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 0828007a-621c-5680-8920-287bead6c2f5
- DOI
- 10.21203/rs.3.rs-6238452/v1
